ANTIHYPERTENSIVE ACTIVITY OF ONCE DAILY METOPROLOL ALONE AND WITH CHLORTHALIDONE AND COMPARISON WITH A TWICE DAILY REGIMEN

被引:5
|
作者
MUIESAN, G
AGABITIROSEI, E
CAROTTI, A
COREA, L
INNOCENTI, P
MONTERVINO, C
PREZIOSO, R
ROMANELLI, G
TOSO, M
MOTOLESE, M
机构
[1] CIBA GEIGY,DEPT CLIN RES,VIALE VILLA MASSIMO 29,I-00161 ROME,ITALY
[2] UNIV MILAN,MED CLIN 5,I-20133 MILAN,ITALY
[3] UNIV PERUGIA,IST SEMEIOT MED,I-06100 PERUGIA,ITALY
[4] CIV HOSP IESI,IESI,ITALY
[5] CIV HOSP CARRARA,CARRARA,ITALY
[6] CIV HOSP TARANTO,TARANTO,ITALY
[7] CIV HOSP ROMANO LOMBARDIA,ROMANO LOMBARDIA,ITALY
[8] CIV HOSP CAMERINO,CAMERINO,ITALY
关键词
D O I
10.1007/BF00547555
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:209 / 213
页数:5
相关论文
共 50 条
  • [21] COMPARISON OF ONCE AND TWICE DAILY ATENOLOL IN HYPERTENSION
    CASTLEDEN, CM
    DATHAN, JRE
    GEORGE, CF
    POSTGRADUATE MEDICAL JOURNAL, 1977, 53 (625) : 679 - 682
  • [22] CLONIDINE-CHLORTHALIDONE COMBINATION ONCE AND TWICE DAILY IN ESSENTIAL-HYPERTENSION
    NOVECK, RJ
    MCMAHON, FG
    JAIN, AK
    RYAN, JR
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1980, 28 (05) : 581 - 586
  • [23] Comparison of once daily and twice daily nisoldipine as monotherapy in essential hypertension
    Davidsson, GK
    Edwards, JS
    Davidson, C
    CONTROLLED CLINICAL TRIALS, 1996, 17 (02): : 117 - 122
  • [24] A once-daily lopinavir/ritonavir-based regimen provides noninferior antiviral activity compared with a twice-daily regimen
    Johnson, Margaret A.
    Gathe, Joseph C., Jr.
    Podzamczer, Daniel
    Molina, Jean-Michel
    Naylor, Christian T.
    Chiu, Yi-Lin
    King, Martin S.
    Podsadecki, Thomas J.
    Hanna, George J.
    Brun, Scott C.
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2006, 43 (02) : 153 - 160
  • [25] Comparison of a once daily with a twice daily subcutaneous nadroparin calcium regimen in the treatment of deep vein thrombosis: The FRAXODI study
    Flessinger, JN
    Charbonnier, BA
    Sixma, JJ
    Wenzel, E
    DAzemar, P
    Sagnard, L
    THROMBOSIS AND HAEMOSTASIS, 1997, : O1582 - O1582
  • [26] Comparison of a once daily with a twice daily subcutaneous low molecular weight heparin regimen in the treatment of deep vein thrombosis
    Charbonnier, BA
    Fiessinger, JN
    Banga, JD
    Wenzel, E
    d'Azemar, P
    Sagnard, L
    THROMBOSIS AND HAEMOSTASIS, 1998, 79 (05) : 897 - 901
  • [27] DOSE FREQUENCY IN THE TREATMENT OF ASTHMATICS WITH INHALED TOPICAL STEROIDS - COMPARISON BETWEEN A TWICE DAILY AND A ONCE DAILY DOSING REGIMEN
    MUNCH, EP
    LAURSEN, LC
    DIRKSEN, A
    WEEKE, ER
    WEEKE, B
    EUROPEAN JOURNAL OF RESPIRATORY DISEASES, 1985, 67 (04): : 254 - 260
  • [28] ONCE-DAILY VS TWICE-DAILY CLONIDINE-CHLORTHALIDONE - A CONTROLLED CLINICAL-TRIAL
    MCMAHON, FG
    RYAN, JR
    LACORTE, WS
    MATHER, FJ
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1983, 33 (06): : 1041 - 1045
  • [29] The pharmacokinetics of didanosine (ddI) are equivalent in a once daily (QD) and twice daily (BID) regimen.
    Hoetelmans, RMW
    van Heeswijk, RPC
    Meenhorst, PL
    Mulder, JW
    Lange, JMA
    Reiss, P
    Beijnen, JH
    AIDS, 1998, 12 : S27 - S27
  • [30] The plasma pharmacokinetics of nevirapine (Viramune®) in a once daily (QD) and twice daily (BID) regimen.
    van Heeswijk, RPG
    Veldkamp, AI
    Wit, FWNM
    Hoetelmans, RMW
    Meenhorst, PL
    Mulder, JW
    Lange, JMA
    Reiss, P
    Beijnen, JH
    AIDS, 1998, 12 : S32 - S32